Summary

Eligibility
for people ages 13 years and up (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
estimated completion
Principal Investigator
by Jonathan Singer, MD
Photo of Jonathan Singer
Jonathan Singer

Description

Summary

The purpose of the study is to follow participants who enrolled in the Lung Transplant Outcomes Group. Clinical data, functional assessments, and surveys will be collected to determine long term graft function and functional status of lung transplant recipients.

Official Title

Long Term Follow up of the Lung Transplant Outcomes Group Cohort

Details

This project will involve both retrospective and prospective data collection from participants enrolled in the LTOG cohort studies. We will perform long-term Chronic Lung Allograft Dysfunction (CLAD) phenotyping of lung transplant recipients who participated in the LTOG cohort studies utilizing data collected for routine clinical visits. Surviving lung transplant recipients who participated in the LTOG cohort studies will be recruited to enroll in the longitudinal portion of the project. The longitudinal component will include follow-up data collection at 6 month intervals while alive until study termination, study withdrawal, or no longer being seen for follow-up at the participating center. Follow-up data collection will include clinical data collected by study coordinators by reviewing medical records, functional assessment through administration of the Short Physical Performance Battery (SPPB), blood collection and surveys. Data from this project will be linked to data and samples collected during the LTOG cohort or ancillary studies.

Keywords

Lung Transplant Failure and Rejection Chronic lung allograft dysfunction Functional status Lung transplantation

Eligibility

You can join if…

Open to people ages 13 years and up

Long-term phenotyping of CLAD

  • Lung transplant recipients who have previously enrolled in the LTOG cohort studies at one of the participating centers

Long-term functional status and well-being

  • Lung transplant recipients who have previously enrolled in the LTOG cohort studies at one of the participating centers
  • Alive

You CAN'T join if...

Long-term phenotyping of CLAD

  • Lung transplant recipient not enrolled in LTOG cohort research studies

Long-term functional status and well-being

  • Lung transplant recipient not enrolled in the LTOG cohort research studies
  • Lung transplant recipient not receiving post-transplant follow-up care at a participating LTOG center

Locations

  • University of California San Francisco accepting new patients
    San Francisco California 94143 United States
  • Stanford University not yet accepting patients
    Stanford California 94305 United States

Lead Scientist at UCSF

  • Jonathan Singer, MD
    Dr. Jonathan Singer is an Associate Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. He serves as an attending physician in the Lung Transplant Program, where he cares for patients with advanced lung disease and lung transplant recipients. Dr. Singer received his undergraduate degree from Stanford University.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of Pennsylvania
ID
NCT04787822
Study Type
Observational
Last Updated